Anzeige
Mehr »
Login
Samstag, 12.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Die Multimilliarden-Dollar-Fonds, die auf NexGold Mining setzen - Was wissen sie?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QFUP | ISIN: US58450V1044 | Ticker-Symbol:
NASDAQ
11.10.24
21:58 Uhr
18,780 US-Dollar
+0,520
+2,85 %
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDIAALPHA INC Chart 1 Jahr
5-Tage-Chart
MEDIAALPHA INC 5-Tage-Chart
GlobeNewswire (Europe)
71 Leser
Artikel bewerten:
(0)

MediaAlpha, Inc.: MediaAlpha Announces Second Quarter 2024 Financial Results

  • Revenue of $178 million, up 110% year over year
  • Transaction Value of $322 million, up 156% year over year
    • Transaction Value from Property & Casualty up 320% year over year to $255 million
    • Transaction Value from Health up 9% year over year to $55 million

LOS ANGELES, July 31, 2024 (GLOBE NEWSWIRE) -- MediaAlpha, Inc. (NYSE: MAX), today announced its financial results for the second quarter ended June 30, 2024.

"We had an outstanding second quarter, underscoring the strength of our business model and solid execution. Our quarterly performance was the strongest in our history, with Transaction Value and Adjusted EBITDA reaching record levels," said MediaAlpha co-founder and CEO Steve Yi. "Looking ahead, we expect continued strong growth and market share gains as the recovery in our Property and Casualty insurance vertical builds momentum."

Second Quarter 2024 Financial Results

  • Revenue of $178.3 million, an increase of 110% year over year;
  • Transaction Value of $321.8 million, an increase of 156% year over year;
  • Gross margin of 17.8%, compared with 16.2% in the second quarter of 2023;
  • Contribution Margin(1) of 18.9%, compared with 19.5% in the second quarter of 2023;
  • Net income was $4.4 million, compared with a net loss of $(20.0) million in the second quarter of 2023; and
  • Adjusted EBITDA(1) was $18.7 million, compared with $3.6 million in the second quarter of 2023.

(1) A reconciliation of GAAP to Non-GAAP financial measures has been provided at the end of this press release. An explanation of these measures is also included below under the heading "Non-GAAP Financial Measures."

Financial Outlook

Our guidance for the third quarter of 2024 reflects a continuation of the recent trends in customer acquisition spending that we have seen in our P&C vertical. As a result, we expect Transaction Value in our P&C insurance vertical to be 40% to 45% higher than Q2 2024 levels. We expect third quarter Transaction Value in our Health vertical to grow year over year at a rate similar to Q2 2024.

For the third quarter of 2024, MediaAlpha currently expects the following:

  • Transaction Value between $415 million - $435 million, representing a 290% year-over-year increase at the midpoint of the guidance range;
  • Revenue between $240 million - $255 million, representing a 232% year-over-year increase at the midpoint of the guidance range;
  • Adjusted EBITDA between $22.0 million and $24.0 million, representing a 541% year-over-year increase at the midpoint of the guidance range. We are projecting Contribution less Adjusted EBITDA to be flat to slightly up compared with Q2 2024 levels.

With respect to the Company's projection of Adjusted EBITDA under "Financial Outlook," MediaAlpha is not providing a reconciliation of Adjusted EBITDA to net income (loss) because the Company is unable to predict with reasonable certainty the reconciling items that may affect net income (loss) without unreasonable effort, including equity-based compensation, transaction expenses and income tax expense. These reconciling items are uncertain, depend on various factors and could significantly impact, either individually or in the aggregate, the corresponding GAAP measures for the applicable period.

For a detailed explanation of the Company's non-GAAP measures, please refer to the appendix section of this press release.

Conference Call Information

MediaAlpha will host a Q&A conference call today to discuss the Company's second quarter 2024 results and its financial outlook for the third quarter of 2024 at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). A live audio webcast of the call will be available on the MediaAlpha Investor Relations website at https://investors.mediaalpha.com. To register for the webcast, click here. Participants may also dial-in, toll-free, at (888) 330-2022 or (646) 960-0690, with passcode 3195092. An audio replay of the conference call will be available following the call and available on the MediaAlpha Investor Relations website at https://investors.mediaalpha.com.

We have also posted to our investor relations website a letter to shareholders. We have used, and intend to continue to use, our investor relations website at https://investors.mediaalpha.com as a means of disclosing material nonpublic information and for complying with our disclosure obligations under Regulation FD.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation statements regarding our expectation of continued strong growth and market share gains as the recovery in our Property and Casualty insurance vertical builds momentum, and our financial outlook for the third quarter of 2024. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as "may," "should," "could," "predict," "potential," "believe," "will likely result," "expect," "continue," "will," "anticipate," "seek," "estimate," "intend," "plan," "projection," "would," and "outlook," or the negative version of those words or other comparable words or phrases of a future or forward-looking nature. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about our industry, management's beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements.

There are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including those more fully described in MediaAlpha's filings with the Securities and Exchange Commission ("SEC"), including the Form 10-K filed on February 22, 2024 and the Forms 10-Q filed on May 2, 2024 and to be filed on or about August 1, 2024. These factors should not be construed as exhaustive. MediaAlpha disclaims any obligation to update any forward-looking statements to reflect events or circumstances that occur after the date of this press release.

Non-GAAP Financial Measures and Operating Metrics

This press release includes Adjusted EBITDA, Contribution, and Contribution Margin, which are non-GAAP financial measures. The Company also presents Transaction Value, which is an operating metric not presented in accordance with GAAP. See the appendix for definitions of Adjusted EBITDA, Contribution, Contribution Margin and Transaction Value, as well as reconciliations to the corresponding GAAP financial metrics, as applicable.

We present Transaction Value, Adjusted EBITDA, Contribution, and Contribution Margin because they are used extensively by our management and board of directors to manage our operating performance, including evaluating our operational performance against budget and assessing our overall operating efficiency and operating leverage. Accordingly, we believe that Transaction Value, Adjusted EBITDA and Contribution Margin provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management team and board of directors. Each of Transaction Value, Adjusted EBITDA and Contribution Margin has limitations as a financial measure and investors should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP.

Contacts:
Investors
Denise Garcia
Hayflower Partners
Denise@HayflowerPartners.com

MediaAlpha, Inc. and subsidiaries
Consolidated Balance Sheets
(Unaudited; in thousands, except share data and per share amounts)
June 30,
2024
December 31,
2023
Assets
Current assets
Cash and cash equivalents$28,659 $17,271
Accounts receivable, net of allowance for credit losses of $684 and $537, respectively 90,696 53,773
Prepaid expenses and other current assets 3,340 3,529
Total current assets 122,695 74,573
Intangible assets, net 22,797 26,015
Goodwill 47,739 47,739
Other assets 4,994 5,598
Total assets$198,225 $153,925
Liabilities and stockholders' deficit
Current liabilities
Accounts payable$90,604 $56,279
Accrued expenses 11,808 11,588
Current portion of long-term debt 8,829 11,854
Total current liabilities 111,241 79,721
Long-term debt, net of current portion 158,023 162,445
Other long-term liabilities 6,931 6,184
Total liabilities$276,195 $248,350
Commitments and contingencies
Stockholders' (deficit)
Class A common stock, $0.01 par value - 1.0 billion shares authorized; 54.7 million and 47.4 million shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively 547 474
Class B common stock, $0.01 par value - 100 million shares authorized; 11.6 million and 18.1 million shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively 116 181
Preferred stock, $0.01 par value - 50 million shares authorized; 0 shares issued and outstanding as of June 30, 2024 and December 31, 2023 - -
Additional paid-in capital 494,995 511,613
Accumulated deficit (520,055) (522,562)
Total stockholders' (deficit) attributable to MediaAlpha, Inc.$(24,397) $(10,294)
Non-controlling interest (53,573) (84,131)
Total stockholders' (deficit)$(77,970) $(94,425)
Total liabilities and stockholders' deficit$198,225 $153,925
MediaAlpha, Inc. and subsidiaries
Consolidated Statements of Operations
(Unaudited; in thousands, except share data and per share amounts)
Three Months Ended
June 30,
Six Months Ended
June 30,
2024 2023 2024 2023
Revenue$178,274 $84,772 $304,923 $196,402
Costs and operating expenses
Cost of revenue 146,589 71,006 249,558 164,268
Sales and marketing 6,316 6,707 12,112 13,701
Product development 5,052 5,061 9,415 10,229
General and administrative 13,824 18,070 24,973 33,825
Total costs and operating expenses 171,781 100,844 296,058 222,023
Income (loss) from operations 6,493 (16,072) 8,865 (25,621)
Other (income) expense, net (1,808) (116) (1,817) 1,265
Interest expense 3,751 3,874 7,596 7,450
Total other expense, net 1,943 3,758 5,779 8,715
Income (loss) before income taxes 4,550 (19,830) 3,086 (34,336)
Income tax expense 130 150 157 228
Net income (loss)$4,420 $(19,980) $2,929 $(34,564)
Net income (loss) attributable to non-controlling interest 800 (5,694) 422 (10,012)
Net income (loss) attributable to MediaAlpha, Inc.$3,620 $(14,286) $2,507 $(24,552)
Net income (loss) per share of Class A common stock
-Basic$0.07 $(0.32) $0.05 $(0.55)
-Diluted$0.07 $(0.32) $0.04 $(0.55)
Weighted average shares of Class A common stock outstanding
-Basic 53,367,896 45,160,646 50,971,172 44,518,890
-Diluted 53,367,896 45,160,646 65,868,384 44,518,890
MediaAlpha, Inc. and subsidiaries
Consolidated Statements of Cash Flows
(Unaudited; in thousands)
Six Months Ended
June 30,
2024 2023
Cash flows from operating activities
Net income (loss)$2,929 $(34,564)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Equity-based compensation expense 17,855 29,489
Non-cash lease expense 395 337
Depreciation expense on property and equipment 126 188
Amortization of intangible assets 3,218 3,458
Amortization of deferred debt issuance costs 380 398
Impairment of cost method investment - 1,406
Credit losses 147 (250)
Tax receivable agreement liability adjustments - 6
Changes in operating assets and liabilities:
Accounts receivable (37,070) 27,659
Prepaid expenses and other current assets 159 2,364
Other assets 249 250
Accounts payable 34,325 (16,177)
Accrued expenses 574 1,777
Net cash provided by operating activities$23,287 $16,341
Cash flows from investing activities
Purchases of property and equipment (164) (47)
Net cash (used in) investing activities$(164) $(47)
Cash flows from financing activities
Payments made for / proceeds received from:
Repayments on long-term debt (7,797) (4,750)
Contributions from QLH's members 756 -
Distributions (1,017) (1,296)
Payments pursuant to tax receivable agreement - (2,822)
Shares withheld for taxes on vesting of restricted stock units (3,677) (1,939)
Net cash (used in) financing activities$(11,735) $(10,807)
Net increase in cash and cash equivalents 11,388 5,487
Cash and cash equivalents, beginning of period 17,271 14,542
Cash and cash equivalents, end of period$28,659 $20,029

Key business and operating metrics and Non-GAAP financial measures

Transaction Value

We define "Transaction Value" as the total gross dollars transacted by our partners on our platform. Transaction Value is an operating metric not presented in accordance with GAAP, and is a driver of revenue based on the economic relationships we have with our partners. Our partners use our platform to transact via Open and Private Marketplace transactions. In our Open Marketplace model, Transaction Value is equal to revenue recognized and revenue share payments to our supply partners represent costs of revenue. In our Private Marketplace model, revenue recognized represents a platform fee billed to the demand partner or supply partner based on an agreed-upon percentage of the Transaction Value for the Consumer Referrals transacted, and accordingly there are no associated costs of revenue. We utilize Transaction Value to assess revenue and to assess the overall level of transaction activity through our platform. We believe it is useful to investors to assess the overall level of activity on our platform and to better understand the sources of our revenue across our different transaction models and verticals.

The following table presents Transaction Value by platform model for the three and six months ended June 30, 2024 and 2023:

Three Months Ended
June 30,
Six Months Ended
June 30,
(dollars in thousands) 2024 2023 2024 2023
Open Marketplace transactions $171,504 $82,856 $293,933 $190,515
Percentage of total Transaction Value 53.3% 65.8% 54.3% 59.7%
Private Marketplace transactions 150,306 43,055 246,983 128,561
Percentage of total Transaction Value 46.7% 34.2% 45.7% 40.3%
Total Transaction Value $321,810 $125,911 $540,916 $319,076

The following table presents Transaction Value by vertical for the three and six months ended June 30, 2024 and 2023:

Three Months Ended
June 30,
Six Months Ended
June 30,
(dollars in thousands) 2024 2023 2024 2023
Property & Casualty insurance $254,576 $60,666 $390,070 $178,590
Percentage of total Transaction Value 79.1% 48.2% 72.1% 56.0%
Health insurance 55,278 50,828 124,365 110,240
Percentage of total Transaction Value 17.2% 40.4% 23.0% 34.5%
Life insurance 7,886 8,359 18,123 18,476
Percentage of total Transaction Value 2.5% 6.6% 3.4% 5.8%
Other(1) 4,070 6,058 8,358 11,770
Percentage of total Transaction Value 1.2% 4.8% 1.5% 3.7%
Total Transaction Value $321,810 $125,911 $540,916 $319,076

(1) Our other verticals include Travel, Education and Consumer Finance.

Contribution and Contribution Margin

We define "Contribution" as revenue less revenue share payments and online advertising costs, or, as reported in our consolidated statements of operations, revenue less cost of revenue (i.e., gross profit), as adjusted to exclude the following items from cost of revenue: equity-based compensation; salaries, wages, and related costs; internet and hosting costs; amortization; depreciation; other services; and merchant-related fees. We define "Contribution Margin" as Contribution expressed as a percentage of revenue for the same period. Contribution and Contribution Margin are non-GAAP financial measures that we present to supplement the financial information we present on a GAAP basis. We use Contribution and Contribution Margin to measure the return on our relationships with our supply partners (excluding certain fixed costs), the financial return on and efficacy of our online advertising costs to drive consumers to our proprietary websites, and our operating leverage. We do not use Contribution and Contribution Margin as measures of overall profitability. We present Contribution and Contribution Margin because they are used by our management and board of directors to manage our operating performance, including evaluating our operational performance against budget and assessing our overall operating efficiency and operating leverage. For example, if Contribution increases and our headcount costs and other operating expenses remain steady, our Adjusted EBITDA and operating leverage increase. If Contribution Margin decreases, we may choose to re-evaluate and re-negotiate our revenue share agreements with our supply partners, to make optimization and pricing changes with respect to our bids for keywords from primary traffic acquisition sources, or to change our overall cost structure with respect to headcount, fixed costs and other costs. Other companies may calculate Contribution and Contribution Margin differently than we do. Contribution and Contribution Margin have their limitations as analytical tools, and you should not consider them in isolation or as substitutes for analysis of our results presented in accordance with GAAP.

The following table reconciles Contribution with gross profit, the most directly comparable financial measure calculated and presented in accordance with GAAP, for the three and six months ended June 30, 2024 and 2023:

Three Months Ended
June 30,
Six Months Ended
June 30,
(in thousands) 2024 2023 2024 2023
Revenue $178,274 $84,772 $304,923 $196,402
Less cost of revenue (146,589) (71,006) (249,558) (164,268)
Gross profit 31,685 13,766 55,365 32,134
Adjusted to exclude the following (as related to cost of revenue):
Equity-based compensation 392 981 2,249 1,947
Salaries, wages, and related 659 907 1,567 1,954
Internet and hosting 126 130 257 280
Other expenses 166 162 369 334
Depreciation 5 10 10 21
Other services 631 566 1,459 1,281
Merchant-related fees 78 7 142 3
Contribution 33,742 16,529 61,418 37,954
Gross margin 17.8% 16.2% 18.2% 16.4%
Contribution Margin 18.9% 19.5% 20.1% 19.3%

Adjusted EBITDA

We define "Adjusted EBITDA" as net income excluding interest expense, income tax benefit (expense), depreciation expense on property and equipment, amortization of intangible assets, as well as equity-based compensation expense and certain other adjustments as listed in the table below. Adjusted EBITDA is a non-GAAP financial measure that we present to supplement the financial information we present on a GAAP basis. We monitor and present Adjusted EBITDA because it is a key measure used by our management to understand and evaluate our operating performance, to establish budgets and to develop operational goals for managing our business. We believe that Adjusted EBITDA helps identify underlying trends in our business that could otherwise be masked by the effect of the expenses that we exclude in the calculations of Adjusted EBITDA. Accordingly, we believe that Adjusted EBITDA provides useful information to investors and others in understanding and evaluating our operating results, enhancing the overall understanding of our past performance and future prospects. In addition, presenting Adjusted EBITDA provides investors with a metric to evaluate the capital efficiency of our business.

Adjusted EBITDA is not presented in accordance with GAAP and should not be considered in isolation of, or as an alternative to, measures presented in accordance with GAAP. There are a number of limitations related to the use of Adjusted EBITDA rather than net income, which is the most directly comparable financial measure calculated and presented in accordance with GAAP. These limitations include the fact that Adjusted EBITDA excludes interest expense on debt, income tax benefit (expense), equity-based compensation expense, depreciation and amortization, and certain other adjustments that we consider to be useful to investors and others in understanding and evaluating our operating results. In addition, other companies may use other measures to evaluate their performance, including different definitions of "Adjusted EBITDA," which could reduce the usefulness of our Adjusted EBITDA as a tool for comparison.

The following table reconciles Adjusted EBITDA with net income (loss), the most directly comparable financial measure calculated and presented in accordance with GAAP, for the three and six months ended June 30, 2024 and 2023:

Three Months Ended
June 30,
Six Months Ended
June 30,
(in thousands) 2024 2023 2024 2023
Net income (loss) $4,420 $(19,980) $2,929 $(34,564)
Equity-based compensation expense 9,221 15,148 17,855 29,489
Interest expense 3,751 3,874 7,596 7,450
Income tax expense 130 150 157 228
Depreciation expense on property and equipment 65 92 126 188
Amortization of intangible assets 1,609 1,729 3,218 3,458
Transaction expenses(1) 559 254 1,217 548
Impairment of cost method investment - - - 1,406
Contract settlement(2) (1,725) - (1,725) -
Changes in TRA related liability - - - 6
Changes in Tax Indemnification Receivable (1) (14) (2) (28)
Settlement of federal and state income tax refunds - - - 3
Legal expenses(3) 711 1,106 1,788 1,439
Reduction in force costs (4) - 1,233 - 1,233
Adjusted EBITDA $18,740 $3,592 $33,159 $10,856

(1) Transaction expenses consist of $0.6 million and $1.2 million of legal and accounting fees incurred by us for the three and six months ended June 30, 2024, respectively, in connection with resale registration statements filed with the SEC. For the three and six months ended June 30, 2023, transaction expenses consist of $0.3 million and $0.5 million of expenses, respectively, in connection with the amendment to the 2021 Credit Facilities, the tender offer filed by the Company's largest shareholder in May 2023, and a resale registration statement filed with the SEC.

(2) Contract settlement consists of $1.7 million of income for the three and six months ended June 30, 2024 recorded in connection with a one-time contract termination fee receivable from one of our partners in the Health vertical that ceased operations during the three months ended June 30, 2024.

(3) Legal expenses of $0.7 million and $1.8 million for the three and six months ended June 30, 2024, respectively, and $1.1 million and $1.4 million for the three and six months ended June 30, 2023, respectively, consist of legal fees incurred in connection with the civil investigative demand received from the Federal Trade Commission in February 2023.

(4) Reduction in force costs for the three and six months ended June 30, 2023 consist of $1.2 million of severance benefits provided to the terminated employees in connection with the RIF Plan. Additionally, equity-based compensation expense includes $0.3 million of charges related to the RIF Plan for the three and six months ended June 30, 2023.


© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.